StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > May will be better than April

<< Previous

Bullboard Posts

Next >>

Comment by Liked2Thinkon May 02, 2021 12:53pm

198 Views

Post# 33110785

RE:RE:RE:May will be better than April

it will be filled at the last possible second as per Stagezero normal operating practices.

We will know May 18th thats the Stage way.

Although I like that time table this time. The ramp up will last through friday in SP and maybe monday. When they release info on a friday especially after close it loses some of its luster by monday.

<< Previous

Bullboard Posts

Next >>

How one company is disrupting PoC testing